Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The Science Behind Bioidentical Claims Its important not to oversimplify
It needs to be considered in conjunction with an exercise program and lifestyle changes in eating and approaching food differently
Cognitive behavioral therapy, structured coaching, or digital health tools may strengthen adherence and motivation
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry Rhea-AI Summary Lexaria (NASDAQ:LEXX) outlines its strategy to develop oral GLP-1 capsule and tablet alternatives using its patented DehydraTECH platform, citing intellectual property established in 20242025 and early-stage commercial discussions with several multinational pharmaceutical companies
US$ 25.21
US$ 25.80
US$ 22.27
US$ 24.91
